[WCl2(NC6H3(i-Pr)2-2,6)(PMe3)3] | 165543-13-5

• 英文名称: [WCl2(NC6H3(i-Pr)2-2,6)(PMe3)3]
• 英文别名: [(2,6-diisopropylphenylimido)WCl2(PMe3)3]
• CAS: 165543-13-5
• 化学式: C₂₁H₄₄Cl₂NP₃W
• 分子量: 658.264
• InChiKey: FDLIBFDAICWBNP-UHFFFAOYSA-L

计算性质

• 辛醇/水分配系数(LogP)：
  None
• 重原子数：
  None
• 可旋转键数：
  None
• 环数：
  None
• sp3杂化的碳原子比例：
  None
• 拓扑面积：
  None
• 氢给体数：
  None
• 氢受体数：
  None

反应信息

• 作为反应物：
  描述：

  [WCl2(NC6H3(i-Pr)2-2,6)(PMe3)3] 、 对甲苯腈 以 甲苯 为溶剂， 以94%的产率得到
  参考文献：
  名称：

  Nielson, Alastair J.; Hunt, Patricia A.; Rickard, Clifton E. F., Journal of the Chemical Society, Dalton Transactions, 1997, # 18, p. 3311 - 3317

  摘要：

  DOI：
• 作为产物：
  描述：

  [(2,6-diisopropylphenylimido)2W(PMe3)3] 、 三氯硅烷 在 B(C₆H₅)3 作用下， 以 氘代甲苯 为溶剂， 生成 [WCl2(NC6H3(i-Pr)2-2,6)(PMe3)3]
  参考文献：
  名称：

  钼和钨的β-声硅烷基和甲硅烷基氢化物†

  摘要：

  双（亚氨基）化合物（RN）2 Mo（PMe 3）n（n = 2，R = t Bu; n = 3，R = 2,6-二甲基苯基（Ar'）和2,6-二异丙基苯基（Ar ））和（RN）2 W（PME 3）3（R =用硅烷2,6-二甲基苯基和2,6-二异丙基），得到四种类型的产品：β-agostic silylamido化合物（RN）（η 3 -RN -SiR' 2 -H ...）的MC1（PME 3）2（M = Mo和W），单（酰亚胺）（RN）的MC1 2（PME 3）3（M = Mo和W），甲硅烷基氢化物二（亚胺基）衍生物（ArN）2W（PME 3）（H）（SiMeCl 2）和Si-CL···w ^桥接产物（ARN）（η 2 -ArN-SiHMeCl-CL···）WCL（PME 3）2。钼化合物（RN）的反应2的Mo（PME 3）米（米与单-和二氯硅烷HSiCl = 2或3）ñ R' 3- Ñ（R'=

  DOI：

  10.1021/ic900591e

文献信息

• Evaluation of the 2,6-diisopropylphenylimido ligand as a steric force in d1 and d2 monomeric octahedral complexes of tungsten
  作者：George R. Clark、Alastair J. Nielson、Clifton E. F. Rickard

  DOI：10.1039/dt9950001907

  日期：——

  Reduction of [WCl4(NC6H3Pr2i-2,6)}(2)] with 2 equivalents of Na-Hg amalgam in the presence of phosphines gave the d(1) complexes [WCl3(NC6H3Pr2i-2,6)L(2)] (L = PMe(3), PMe(2)Ph or PMePh(2)). The crystal structure of [WCl3(NC6H3Pr2i-2,6)(PMe(3))(2)] 1 shows the 2,6-diisopropylphenylimido ligand exerts a greater trans influence than a phenylimido ligand but only slightly more steric pressure. Solutions of complex 1 react with air to give [WCl3(NC(6)H(3)Pr(2)(-)2,6)(PMe(3))(OPMe(3))] 2 for which the crystal structure shows the OPMe(3) ligand lying trans to the imido ligand. Reduction of [WCl4(NC6H3Pr2i-2,6)}(2)] with 4 equivalents of Na-Hg amalgam in the presence of phosphines gave the d(2) complexes [WCl2(NC(6)H(3)Pr(2)(-)2,6)L(3)] (L = PMe(3) or PMe(2)Ph). Complex [WCl2(NC6H3Pr2i-2,6)(PMe(3))(3)] 3 reacts with alkynes L' to give the complexes [WCl2(NC6H3Pr2i-2,6)L'(PMe(3))(2)] (L' = PhC(2)Ph, MeC(2)Me or PhC(2)H) for which H-1 and C-13-H-1} NMR spectral data were obtained. The crystal structure of [WCl2(NC6H3Pr2i-2.6)(PhC(2)H)(PMe(3))(2)] 6 shows cis-chloro ligands, trans-phosphines and mutually cis-imido and alkyne ligands. The C(6) isopropyl group rotates to minimise the isopropyl group and PhC(2)H interaction. The complex [WCl2(NC6H3Pr2i-2.6)(PhC(2)Ph)(PMe(2)Ph)(2)] can be prepared but not [WCl2(NC6H3Pr2i-2,6)(PhC(2)Ph)(PMePh(2))(2)]. Reduction of [WCl3(NC6H3Pr2i-2.6)(PMe(3))(2)] by Na-Hg amalgam in the presence of olefins gave the complexes [WCl2(NC6H3Pr2i-2,6)L'(PMe(3))(2)] (L' = CH2CH2 or CH(2)CHMe). A more bulky organoimido ligand or a large phosphine is needed to exert steric pressure in all the complexes prepared.